These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Johal SS; Hammond J; Solomon K; James PD; Mahida YR Gut; 2004 May; 53(5):673-7. PubMed ID: 15082585 [TBL] [Abstract][Full Text] [Related]
29. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital. Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443 [TBL] [Abstract][Full Text] [Related]
30. Piperacillin/tazobactam in complicated urinary tract infections. Nowé P Intensive Care Med; 1994 Jul; 20 Suppl 3():S39-42. PubMed ID: 7962988 [TBL] [Abstract][Full Text] [Related]
31. [A national multicenter study of the in-vitro activity of piperacillin-tazobactam. The Spanish Piperacillin-Tazobactam Group]. Gobernado M; Bouza E; Perea E; Alvarez-Bravo J; García Rodríguez JA Rev Esp Quimioter; 1998 Jun; 11(2):139-46. PubMed ID: 9795299 [TBL] [Abstract][Full Text] [Related]
32. Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment--a retrospective analysis in 38 children with cystic fibrosis. Reichardt P; Handrick W; Linke A; Schille R; Kiess W Infection; 1999; 27(6):355-6. PubMed ID: 10624596 [TBL] [Abstract][Full Text] [Related]
33. Immune thrombocytopenia caused by piperacillin/tazobactam. Pérez-Vázquez A; Pastor JM; Riancho JA Clin Infect Dis; 1998 Sep; 27(3):650-1. PubMed ID: 9770174 [No Abstract] [Full Text] [Related]
34. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients. Hess U; Böhme C; Rey K; Senn HJ Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210 [TBL] [Abstract][Full Text] [Related]
35. [Severe forms of pseudomembranous colitis caused by Clostridium difficile]. Mohammedi I; Gachot B; Souweine B; Vachon F Ann Fr Anesth Reanim; 1995; 14(4):362-5. PubMed ID: 8572394 [TBL] [Abstract][Full Text] [Related]
37. Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. Ng TM; Khong WX; Harris PN; De PP; Chow A; Tambyah PA; Lye DC PLoS One; 2016; 11(4):e0153696. PubMed ID: 27104951 [TBL] [Abstract][Full Text] [Related]
38. Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait. Jamal WY; Rotimi VO PLoS One; 2016; 11(8):e0161411. PubMed ID: 27536994 [TBL] [Abstract][Full Text] [Related]
39. Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates. Pillay T; Pillay DG; Adhikari M; Sturm AW Am J Perinatol; 1998 Jan; 15(1):47-51. PubMed ID: 9475688 [TBL] [Abstract][Full Text] [Related]
40. Antibiotics "just-in-case" in a patient with aspiration pneumonitis. Joundi RA; Wong BM; Leis JA JAMA Intern Med; 2015 Apr; 175(4):489-90. PubMed ID: 25665174 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]